IndiaOne Finance - Company Dashboard

Governance Classic Home

Divis Laboratories LtdPharmaceuticalsINE361B01024Consolidated₹9375.00+52.00 (+0.56%)Jun-26

Valuation

Market Cap₹2.49L Cr

TTM PE85.06x

Forward PE83.47x

PEG6.12

Book Value₹631.37

P/B14.85x

TTM EPS₹110.21

Fwd EPS₹112.32

TTM Revenue₹11.23K Cr

TTM PAT₹2.93K Cr

TTM EBITDA₹3.97K Cr

TTM EBIT₹3.48K Cr

Last Qtr PAT₹902.00 Cr

Last Qtr EBITDA₹1.26K Cr

Last Qtr EBIT₹1.12K Cr

Profitability

ROE17.45%

ROCE23.03%

TTM NPM26.05%

TTM EBITDA %35.33%

Curr OPM28.69%

Last OPM25.15%

Curr NPM—

Last NPM—

Curr EPS₹33.95

Last EPS₹28.31

Balance sheet

Equity₹53.00 Cr

Reserve₹16.71K Cr

Total Debt₹1.00 Cr

D/E0.00x

Interest %0.67%

Curr Interest₹6.00 Cr

Price / range

Close₹9375.00

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.56%

1W+0.57%

1M+9.16%

3M+38.54%

6M+52.57%

1Y+53.63%

2Y+71.44%

3Y+147.77%

5Y+83.01%

Diwali+47.81%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	2,974+26.2%	2,793	2,578	2,660	2,357	10,388
Other Income	63	154	87	146	119	506
Total Income	3,037+22.7%	2,947	2,665	2,806	2,476	10,894
Interest	6	6	6	8	3	23
Expenditure	-1,872-8.3%	-1,976	-1,793	-1,886	-1,729	-7,384
PBDT	0	0	0	0	0	0
EBITDA	1,240+66.9%	943	907	895	743	3,488
Depreciation	-132	-120	-116	-113	-112	-461
EBIT	1,108+75.6%	823	791	782	631	3,027
PBT	1,165+56.0%	971	798	920	747	3,436
Tax	-274	-215	-200	-224	-190	-829
Equity	53	53	53	0	53	53
OPM	38.36	32.95	29.94	34.59	30.17	31.54
Net Profit	891+60.0%	756	598	696	557	2,607
NPM	29.34	25.65	22.44	26.17	22.50	23.93
EPS	33.55+60.1%	28.44	22.56	26.24	20.95	98.19

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	10,388+12.9%	9,198+20.0%	7,665+0.5%	7,625.30-14.1%	8,879.82+30.6%	6,798.61
Other Income	506	352	337	349.01	111.26	62.53
Total Income	10,894+14.1%	9,550+19.3%	8,002+0.3%	7,974.31-11.3%	8,991.08+31.0%	6,861.14
Expenditure	-7,384-11.5%	-6,621-12.8%	-5,870-4.4%	-5,620.21-5.8%	-5,314.56-25.5%	-4,233.27
Interest	-23	-1	-3	-0.52	-0.65	-0.69
PBDT	0	0	0	0	0	0
EBITDA	3,488+17.1%	2,979+37.0%	2,174-7.4%	2,347.68-39.4%	3,876.46+37.4%	2,820.68
Depreciation	-461	-401	-376	-342.07	-310.55	-254.65
EBIT	3,027+17.4%	2,578+43.4%	1,798-10.4%	2,005.61-43.8%	3,565.91+39.0%	2,566.03
PBT	3,436+17.3%	2,929+37.4%	2,132-9.4%	2,354.10-36.0%	3,676.52+39.9%	2,627.87
Tax	-829	-720	-556	-545.95	-727.98	-673.15
Equity	53	53	0	0	0	0
OPM (%)	31.54	30.67	27.00	30.00	41.00	38.00
Net Profit	2,607+18.0%	2,209+40.2%	1,576-12.8%	1,808.15-38.7%	2,948.54+50.8%	1,954.72
NPM (%)	23.93	23.13	20.00	23.00	33.00	28.00
EPS (Rs)	98.19+18.0%	83.20+40.1%	59.37-12.8%	68.11-38.7%	111.07+50.8%	73.63
CEPS	98.19	83.20	59.37	68.11	111.07	73.63

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	3,080+27.8%	2,831	2,604	2,715	2,410	10,560
Other Income	64	155	88	145	119	507
Total Income	3,144+24.3%	2,986	2,692	2,860	2,529	11,067
Interest	6	6	6	8	3	23
Expenditure	-1,964-9.4%	-2,023	-1,838	-1,948	-1,796	-7,605
PBDT	0	0	0	0	0	0
EBITDA	1,255+72.2%	934	890	888	729	3,441
Depreciation	-133	-120	-118	-113	-112	-463
EBIT	1,122+81.8%	814	772	775	617	2,978
PBT	1,180+61.0%	963	780	912	733	3,388
Tax	-278	-212	-197	-223	-188	-820
Equity	53	53	53	0	53	53
OPM	37.53	32.25	28.97	31.89	28.98	30.61
Net Profit	902+65.5%	751	583	689	545	2,568
NPM	28.69	25.15	21.66	24.09	21.55	23.20
EPS	33.95+65.7%	28.31	21.98	25.97	20.49	96.75

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	10,560+12.8%	9,360+19.3%	7,845+1.0%	7,767.51-13.3%	8,959.83+28.6%	6,969.40
Other Income	507	352	339	344.66	113.87	62.56
Total Income	11,067+14.0%	9,712+18.7%	8,184+0.9%	8,112.17-10.6%	9,073.70+29.0%	7,031.96
Expenditure	-7,605-11.9%	-6,796-12.9%	-6,021-4.8%	-5,743.54-6.6%	-5,390.20-23.5%	-4,365.92
Interest	-23	-2	-3	-0.67	-0.80	-0.87
PBDT	0	0	0	0	0	0
EBITDA	3,441+15.9%	2,968+34.6%	2,205-6.9%	2,367.82-39.0%	3,881.94+35.7%	2,859.94
Depreciation	-463	-402	-378	-343.18	-311.51	-255.59
EBIT	2,978+16.1%	2,566+40.4%	1,827-9.8%	2,024.64-43.3%	3,570.43+37.1%	2,604.35
PBT	3,388+16.2%	2,916+34.8%	2,163-8.7%	2,368.63-35.7%	3,683.50+38.2%	2,666.04
Tax	-820	-725	-563	-545.25	-723.05	-681.75
Equity	53	53	0	0	0	0
OPM (%)	30.61	30.02	26.43	29.20	40.60	37.91
Net Profit	2,568+17.2%	2,191+36.9%	1,600-12.3%	1,823.38-38.4%	2,960.45+49.2%	1,984.29
NPM (%)	23.20	22.56	19.55	22.48	32.63	28.22
EPS (Rs)	96.75+17.2%	82.53+36.9%	60.27-12.3%	68.69-38.4%	111.52+49.2%	74.75
CEPS	96.75	82.53	60.27	68.69	111.52	74.75

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	30	24 Jul 2026
2025	Final Dividend	30	25 Jul 2025
2024	Final Dividend	30	02 Aug 2024
2023	Final Dividend	30	11 Aug 2023
2022	Final Dividend	30	11 Aug 2022
2021	Final Dividend	20	17 Aug 2021
2020	Interim Dividend	16	25 Feb 2020
2019	Final Dividend	16	14 Aug 2019
2018	Final Dividend	10	31 Aug 2018
2017	Final Dividend	10	15 Sep 2017
2016	Interim Dividend	10	17 Mar 2016
2015	Final Dividend	20	06 Aug 2015
2014	Final Dividend	20	31 Jul 2014
2013	Final Dividend	15	25 Jul 2013
2012	Final Dividend	13	26 Jul 2012
2011	Final Dividend	10	16 Jun 2011
2010	Final Dividend	6	02 Jul 2010
2009	Final Dividend	6	15 Jun 2009
2008	Final Dividend	4	26 Jun 2008

Bonus

Year	Ratio	Ex-Date
2015	1:1	23 Sep 2015
2009	1:1	30 Jul 2009

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split